跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZTALMY 50 MG/ML SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZTALMY 50 MG/ML SUSPENSION ORAL
Approved
STANDARD
ZTALMY 50 MG/ML SUSPENSION ORAL
Immedica Pharma Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 18, 2024
Approval ID
d1252c4ef5bc84e9
Company
Immedica Pharma Ab
Type
Standard
Approval Details
Approval Id
d1252c4ef5bc84e9
Drug Cima Aemps Name
ZTALMY 50 MG/ML SUSPENSION ORAL
Register Number
1231743001
Holder Company Name
Immedica Pharma Ab
Marketing Company Name
Orion Pharma S.L.
Holder Company Detail Path
/organization/immedica-pharma-ab
Authorization Date
2024-06-18
Dosage Form
SUSPENSIÓN ORAL
Dose
50 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Immedica Pharma Ab
Company Detail Path
/organization/immedica-pharma-ab
Company Information
Pharmaceutical Company Name
Immedica Pharma Ab
Country Name
Belgium
City Name
unknown,country_be
Address
Unknown Belgian address 0
Website
http://www.immedica.com
Active Ingredients
GANAXOLONA
50 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 18, 2024
Approval ID
d1252c4ef5bc84e9
Type
Standard
Back to CIMA-AEMPS Approvals